Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists. Heesen C, Kleiter I, Nguyen F, Schäffler N, Kasper J, Köpke S, Gaissmaier W Mult Scler. 2010 Dec; 16(12):1507-12. PMID: 20826527. Abstract CommentRecommendBookmarkWatch